Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)
- 29 February 2004
- Vol. 63 (2) , 309-313
- https://doi.org/10.1016/j.urology.2003.09.083
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/mlUrology, 2002
- Parameterization of Multivariate Random Effects Models for Categorical DataBiometrics, 2001
- Prostate-specific antigen-based early detection of prostate cancer—validation of screening without rectal examinationUrology, 2001
- Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancerThe Prostate, 2000
- Lowering PSA cutoffs to enhance detection of curable prostate cancerUrology, 2000
- PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGENJournal of Urology, 2000
- Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)International Journal of Cancer, 1999
- Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)The Prostate, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Evaluation of prostate‐specific antigen, digital rectal examination and transrectal ultrasonography in population‐based screening for prostate cancer: improving the efficiency of early detectionBritish Journal of Urology, 1997